ICL Group stock fell 18% since our cautious call. Potash margin pressure hit Q2 EBITDA. The Indian contract in October is the next catalyst. Alpha Score 33 on YARIY.
ICL Group (NYSE:ICL) has been a name I covered closely early this year, and the caution I flagged then has played out. The stock is down roughly 18% since my initial call, underperforming the broader fertilizer sector. The thesis was never about a broken business – ICL's potash and specialty phosphate operations remain structurally sound – but about timing and valuation.
The concern centered on margin compression in the commodity potash segment. Global potash prices softened through the first half as buyers in key markets like Brazil and India pushed back against elevated prices, waiting for supply to catch up. ICL's Q2 results confirmed the squeeze: potash segment EBITDA fell 14% year over year to $186 million, even as volumes held steady. The specialty phosphate business, which ICL has positioned as a higher-margin buffer, grew revenue 8% but could not fully offset the commodity drag.
ICL is not alone here. Nutrien (NTR) and Mosaic (MOS) reported similar pressure. What made ICL more exposed, in my view, was its higher valuation relative to peers at the start of the year. The stock traded at 14x forward earnings in January, a premium to Nutrien's 11x and Mosaic's 10x. That premium assumed the specialty portfolio would insulate earnings from the commodity cycle. The Q2 numbers showed it does not – not entirely.
A trader I spoke with at a London-based resource fund said the selloff felt
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.